Publication:
Coronavirus Disease 2019 Diagnostics: Key to Africa's Recovery

dc.contributor.authorEnany, Shymaa
dc.contributor.authorNaidoo, Sanushka
dc.contributor.authorGitaka,Jesse
dc.contributor.authorSuliman,Sara
dc.contributor.authorBaptista,Sara
dc.contributor.authorOyedemi, Blessing Mbabie
dc.contributor.authorNepolo, Emmanuel
dc.date.accessioned2024-06-10T12:38:19Z
dc.date.available2024-06-10T12:38:19Z
dc.date.issued2022-01-12
dc.description.abstractWith the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa.
dc.identifier.citationPB - Mary Ann Liebert, Inc., publishers N2 - With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa. AB - With the coronavirus disease of 2019 (COVID-19) becoming a full-blown outbreak in Africa, coupled with many other challenges faced on the African continent, it is apparent that Africa continues to need diagnostics to enable case identification and recovery to this and future challenges. With the slow vaccination rates across the continent, reliable diagnostic tests will be in demand, likely for years to come. Thus, access to reliable diagnostic tools to detect the severe acute respiratory syndrome of the coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19, remain a critical pillar to monitor and contain new waves of COVID-19. Increasing the local capacity to manufacture and roll-out vaccines and decentralized COVID-19 testing are paramount for fighting the pandemic in Africa. SN - 1044-5498 M3 - doi: 10.1089/dna.2021.0540 UR - https://doi.org/10.1089/dna.2021.0540
dc.identifier.urihttps://doi.org/10.1089/dna.2021.0540
dc.identifier.urihttps://erepository.mku.ac.ke/handle/123456789/5869
dc.language.isoen
dc.publisherMaryann Liebert
dc.subjectMEDICINE::Microbiology, immunology, infectious diseases::Infectious diseases
dc.subjectSurgery & Diagnosis
dc.subjectMedicine
dc.subjectViral diseases
dc.titleCoronavirus Disease 2019 Diagnostics: Key to Africa's Recovery
dc.typeArticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
naidoo-et-al-2022-coronavirus-disease-2019-diagnostics-key-to-africa-s-recovery(1).pdf
Size:
94.23 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: